Rocuronium-sugammadex as an alternative muscle relaxant to succinylcholine in electroconvulsive therapy: A meta-analysis

doi:10.5498/wjp.v16.i2.112462

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 2

This Article

(29)

(49)

(0)

(11)

(835)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Psychiatry

ISSN

2220-3206

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Psychiatry. Feb 19, 2026; 16(2): 112462
Published online Feb 19, 2026. doi: 10.5498/wjp.v16.i2.112462

Full Size Figure Download Figure

Figure 2 Risk of bias assessment using mixed methods appraisal tool (version 2018). QRS: Quantitative randomized studies; QNRS: Quantitative non-randomized study; QDS: Quantitative descriptive study; C: Can not say.

Citation: Anand R, Nag DS, Gope RL, Sahoo MK, Bhushan P, Pal BD, Patel R, Shivani S, Bharadwaj MK, Ansari MA. Rocuronium-sugammadex as an alternative muscle relaxant to succinylcholine in electroconvulsive therapy: A meta-analysis. World J Psychiatry 2026; 16(2): 112462
URL: https://www.wjgnet.com/2220-3206/full/v16/i2/112462.htm
DOI: https://dx.doi.org/10.5498/wjp.v16.i2.112462

Anand R, Nag DS, Gope RL, Sahoo MK, Bhushan P, Pal BD, Patel R, Shivani S, Bharadwaj MK, Ansari MA. Rocuronium-sugammadex as an alternative muscle relaxant to succinylcholine in electroconvulsive therapy: A meta-analysis. World J Psychiatry 2026; 16(2): 112462 [PMID: 41641191 DOI: 10.5498/wjp.v16.i2.112462]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.